«We want to enable medical personnel to drive better healthcare
outcomes for patients while enhancing decision-making
and reducing Costs.»
outcomes for patients while enhancing decision-making
and reducing Costs.»
|
WHO WE ARE
Founded in 2014, illumiSonics is a privately held medical device company with offices and R&D facilities in Waterloo, ON, Canada. Our executive team of medical device leaders holds an excellent track record of successfully building companies and improving outcomes for clinicians and patients. Our technical R&D teams are made up of the pioneers in PARS® technology.
|
WHAT WE DO
illumiSonics develops, patents and commercializes PARS® advanced optical imaging systems for a wide range of pre-clinical and clinical applications. Our proprietary PARS® photoabsorption remote sensing technology is a revolution in optical imaging, and we work with market leading partners to develop systems for specific applications.
|
The PARS® Technology
Photon Absorption Remote Sensing
PARS can capture all light-matter-interactions
(absorption, scattering and emission) to offer unique and accurate imaging.
Unlike other optical imaging modalities, it delivers both functional and molecular imaging in close to real-time.
(absorption, scattering and emission) to offer unique and accurate imaging.
Unlike other optical imaging modalities, it delivers both functional and molecular imaging in close to real-time.
News |
Our People |
Our Partners |